How a common virus and a weakened immune system contribute to the disease
Bring a printable list of questions to your appointment, or share this page with someone who needs it.
Merkel cell carcinoma (MCC) has two distinct causes that often overlap: a common skin virus called the Merkel cell polyomavirus, and years of ultraviolet (UV) damage from the sun or tanning beds. Running underneath both is the immune system — how well it keeps stray abnormal cells in check.
Understanding these drivers explains why MCC clusters in older, fair-skinned, sun-exposed people and in people whose immune systems are suppressed — and why immunotherapy has become such an effective treatment.
The Merkel cell polyomavirus was discovered in MCC tumors in 2008. It is one of the most widespread viruses in people — the large majority of healthy adults carry it on their skin without ever knowing, and it causes no illness on its own. It is found in roughly 80% of MCC tumors in North America and Europe.
Cancer requires two rare accidents. First, a piece of viral DNA becomes permanently stitched into the DNA of a skin cell (integration). Second, the viral DNA acquires a mutation that leaves a growth-promoting viral protein (large T antigen) active while disabling the part that would let the virus replicate and move on. The result is a cell locked into constant growth signals. This sequence happens in only a tiny fraction of the millions of people who carry the virus.
Virus-positive tumors carry foreign viral proteins that the immune system can recognize — one reason checkpoint immunotherapy works well in MCC. People with virus-positive tumors can also often have a blood test (an antibody to the large T antigen, sometimes called the "AMERK" test) that rises when disease returns, adding an early-warning layer to follow-up monitoring.
About one in five MCCs in sun-exposed populations is virus-negative. These tumors instead carry a very high burden of mutations bearing the fingerprint of UV light — the same kind of damage that drives most basal and squamous cell skin cancers. They tend to occur on the most sun-exposed skin of the head and neck in older adults with a long history of sun exposure.
Practically, this is why sun protection still matters even though a virus is involved in most cases: UV both causes a share of MCCs directly and weakens the skin's local immune defenses against the virus-driven ones.
A healthy immune system routinely spots and destroys cells that start down the path to MCC. When that surveillance is weakened, MCC becomes both more likely and more aggressive. Higher-risk groups include:
Immunosuppressed patients account for roughly 10% of MCC cases but a disproportionate share of poor outcomes, and analyses have linked immunosuppression to higher recurrence and lower survival. If this applies to you, tell every clinician who evaluates a new skin lump, and ask about closer surveillance after treatment.
Most Merkel cell carcinomas begin when a widespread, normally harmless virus becomes trapped and mutated inside a skin cell; the rest arise from long-term UV damage. In both routes, the immune system is the decisive factor — which is why immunosuppression raises risk and worsens outcomes, and why drugs that unleash the immune system have transformed treatment of advanced disease.
None of this is something you caused, and the virus is not something you can "catch" as cancer. What you can act on: protect your skin from UV, and if your immune system is suppressed, push for vigilant skin checks.
Disclaimer: Educational only. Not a substitute for professional medical advice. Always consult your dermatologist or oncologist about your personal diagnosis and treatment plan.
Chat with our AI guide for personalized information about Merkel cell carcinoma
Chat with the Navigator